Efficacy of single intravitreal injection of Ranibizumab for diabetic macular edema

AIM: To observe the efficacy of single time intravitreal injection of ranibizumab(IVR)in patients with diabetic macular edema(DME).<p>METHODS: Twenty-nine cases of DME patients who complied with diagnostic criteria for clinically significant macular edema were enrolled in this retrospective st...

Full description

Bibliographic Details
Main Authors: Yu-Dong Fu, Xu-Xia Meng, Da-Bo Wang, Zhao-Dong Du, Hai-Tao Wang
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2017-03-01
Series:Guoji Yanke Zazhi
Subjects:
Online Access:http://ies.ijo.cn/cn_publish/2017/3/201703029.pdf
_version_ 1818135973570019328
author Yu-Dong Fu
Xu-Xia Meng
Da-Bo Wang
Zhao-Dong Du
Hai-Tao Wang
author_facet Yu-Dong Fu
Xu-Xia Meng
Da-Bo Wang
Zhao-Dong Du
Hai-Tao Wang
author_sort Yu-Dong Fu
collection DOAJ
description AIM: To observe the efficacy of single time intravitreal injection of ranibizumab(IVR)in patients with diabetic macular edema(DME).<p>METHODS: Twenty-nine cases of DME patients who complied with diagnostic criteria for clinically significant macular edema were enrolled in this retrospective study. All the patients receive single dose IVR(0.05mL, 10mg/mL), and no other eye treatments were performed before this operation. All data were recorded before and after injection of 4, 8, and 16wk. Best corrected visual acuity(BCVA), central foveal thickness(CFT), the integrity of the foveal photoreceptor layer on optical coherence tomography were analyzed. The data of photoreceptor integrity and photoreceptor defect group also were recorded and analyzed.<p>RESULTS: BCVA was significantly improved at 4 and 8wk after IVR(<i>P</i>=0.009,0.003), macular edema was relieved, and CFT was significantly lower in the same time(<i>P</i><0.01,<i>P</i>=0.001). But the drug action was weakened in 16wk, BCVA was poorer than that in 4 and 8wk(<i>P</i>=0.043,0.019), macular edema recurred CFT increased(<i>P</i><0.01,<i>P</i>=0.005). BCVA and CFT value were not statistically significant different between 4 and 8wk(<i>P</i>=0.074,0.420). There was no significant change in BCVA before and after surgery in photoreceptor complete group(<i>P</i>=0.076), but CFT was lower obviously(<i>P</i>=0.001). BCVA and CFT value were better in photoreceptor defect group after IVR in 4wk(<i>P</i><0.01,<i>P</i><0.01). There was significant correlation between visual acuity and photoreceptor integrity before and after treatment in 4wk(<i>P</i>=0.015, 0.024).<p> CONCLUSION: Patients with DME treated with ranibizumab obtained great improvements in vision and macular edema in the short term. Macular photoreceptor integrity was closely related to the vision. IVR may also repair the macular photoreceptor damage.
first_indexed 2024-12-11T09:33:01Z
format Article
id doaj.art-63e319042ff64d15811cd2193e687f8a
institution Directory Open Access Journal
issn 1672-5123
1672-5123
language English
last_indexed 2024-12-11T09:33:01Z
publishDate 2017-03-01
publisher Press of International Journal of Ophthalmology (IJO PRESS)
record_format Article
series Guoji Yanke Zazhi
spelling doaj.art-63e319042ff64d15811cd2193e687f8a2022-12-22T01:12:57ZengPress of International Journal of Ophthalmology (IJO PRESS)Guoji Yanke Zazhi1672-51231672-51232017-03-0117350450710.3980/j.issn.1672-5123.2017.3.29Efficacy of single intravitreal injection of Ranibizumab for diabetic macular edemaYu-Dong Fu0Xu-Xia Meng1Da-Bo Wang2Zhao-Dong Du3Hai-Tao Wang4Department of Ophthalmology, the Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong Province, ChinaDepartment of Ophthalmology, the Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong Province, ChinaDepartment of Ophthalmology, the Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong Province, ChinaDepartment of Ophthalmology, the Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong Province, ChinaDepartment of Ophthalmology, the Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong Province, ChinaAIM: To observe the efficacy of single time intravitreal injection of ranibizumab(IVR)in patients with diabetic macular edema(DME).<p>METHODS: Twenty-nine cases of DME patients who complied with diagnostic criteria for clinically significant macular edema were enrolled in this retrospective study. All the patients receive single dose IVR(0.05mL, 10mg/mL), and no other eye treatments were performed before this operation. All data were recorded before and after injection of 4, 8, and 16wk. Best corrected visual acuity(BCVA), central foveal thickness(CFT), the integrity of the foveal photoreceptor layer on optical coherence tomography were analyzed. The data of photoreceptor integrity and photoreceptor defect group also were recorded and analyzed.<p>RESULTS: BCVA was significantly improved at 4 and 8wk after IVR(<i>P</i>=0.009,0.003), macular edema was relieved, and CFT was significantly lower in the same time(<i>P</i><0.01,<i>P</i>=0.001). But the drug action was weakened in 16wk, BCVA was poorer than that in 4 and 8wk(<i>P</i>=0.043,0.019), macular edema recurred CFT increased(<i>P</i><0.01,<i>P</i>=0.005). BCVA and CFT value were not statistically significant different between 4 and 8wk(<i>P</i>=0.074,0.420). There was no significant change in BCVA before and after surgery in photoreceptor complete group(<i>P</i>=0.076), but CFT was lower obviously(<i>P</i>=0.001). BCVA and CFT value were better in photoreceptor defect group after IVR in 4wk(<i>P</i><0.01,<i>P</i><0.01). There was significant correlation between visual acuity and photoreceptor integrity before and after treatment in 4wk(<i>P</i>=0.015, 0.024).<p> CONCLUSION: Patients with DME treated with ranibizumab obtained great improvements in vision and macular edema in the short term. Macular photoreceptor integrity was closely related to the vision. IVR may also repair the macular photoreceptor damage.http://ies.ijo.cn/cn_publish/2017/3/201703029.pdfdiabetic macular edemaranibizumaboptical coherence tomographyphotoreceptorphotoreceptor
spellingShingle Yu-Dong Fu
Xu-Xia Meng
Da-Bo Wang
Zhao-Dong Du
Hai-Tao Wang
Efficacy of single intravitreal injection of Ranibizumab for diabetic macular edema
Guoji Yanke Zazhi
diabetic macular edema
ranibizumab
optical coherence tomography
photoreceptor
photoreceptor
title Efficacy of single intravitreal injection of Ranibizumab for diabetic macular edema
title_full Efficacy of single intravitreal injection of Ranibizumab for diabetic macular edema
title_fullStr Efficacy of single intravitreal injection of Ranibizumab for diabetic macular edema
title_full_unstemmed Efficacy of single intravitreal injection of Ranibizumab for diabetic macular edema
title_short Efficacy of single intravitreal injection of Ranibizumab for diabetic macular edema
title_sort efficacy of single intravitreal injection of ranibizumab for diabetic macular edema
topic diabetic macular edema
ranibizumab
optical coherence tomography
photoreceptor
photoreceptor
url http://ies.ijo.cn/cn_publish/2017/3/201703029.pdf
work_keys_str_mv AT yudongfu efficacyofsingleintravitrealinjectionofranibizumabfordiabeticmacularedema
AT xuxiameng efficacyofsingleintravitrealinjectionofranibizumabfordiabeticmacularedema
AT dabowang efficacyofsingleintravitrealinjectionofranibizumabfordiabeticmacularedema
AT zhaodongdu efficacyofsingleintravitrealinjectionofranibizumabfordiabeticmacularedema
AT haitaowang efficacyofsingleintravitrealinjectionofranibizumabfordiabeticmacularedema